The company notes their next-generation system, the endoPRO 20|20 pathology engine offers functionality that leverages HL7 Interfacing and PENTAX Connect to create interoperability between disparate hospital systems, delivering efficient procedure reporting and quality indicators.

7D Surgical Beau Standish, Chief Executive Officer said, “Aggressively expanding our international footprint has been a strategic priority for the company in 2020.” He added, “We have now successfully launched in the United States, Canada, Singapore, Australia, New Zealand, and the Caribbean and are excited to enter into the European market to share our machine-vision technology with the global healthcare community.”

Modulim can now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.

“This year has been a pivotal year for Samsung in moving forwards new solutions across a variety of areas. We are looking forward to putting on display our advancements within ultrasound, digital radiography and mobile CT modalities,” stated Yongkwan Kim, Head of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Our innovative solutions demonstrate Samsung’s commitment to leveraging our innovation engine to better address the needs of healthcare providers and their patients.”